In addition to recurrent TP53 point mutations and CNVs, these studies identified two other recurrently mutated genes: SETD2 (histone lysine methyltransferase) and DMD (dystrophin) not previously identified in human OSA. The gene discussed is SETD2; the disease is obstructive sleep apnea syndrome.